REVISTIM-XX: Effects of tDCS Combined With VR on Anxious Ruminations in Healthy Subjects With a Vulnerability to Rumination
Study Details
Study Description
Brief Summary
This study proposes: to evaluate 1) whether the combination of virtual reality (VR) and active tDCS provides better rumination attenuation than the combination of VR and tDCS placebo 2) the acceptability and experiential experience of combining these two well known medical devices.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Inclusion visit:
-
Confirmation of eligibility criteria
-
Written informed consent
Visit 1 and 2 (or end of study visit) :
Before first ruminations induction :
-
Completion of Brief State Rumination Inventory (BSRI), State-Trait Anxiety (STAI), Inventory, Visual Analogic Scale (VAS), Ruminative Response Scale - Short Form (RRS-SF), Beck depression Inventory (BDI)
-
EEG recording
Then Procedure for inducing ruminations using a pre-recorded voice listened to in an audio headset alternating statements promoting a positive, neutral and negative introspection and self-judgment attitude (the latter are heard at the end to initiate the rumination process) over 8 minutes
Then
-
Completion of Brief State Rumination Inventory (BSRI), Inventory, Visual Analogic Scale (VAS), Beck depression Inventory (BDI),
-
EEG recording
-
Pulse and blood pressure measurements
Then immersion in a relaxing virtual environment for 20 minutes with active or sham placebo.
• Cutaneous conductance measurement and eye-tracking during immersion
At the end of immersion :
-
Completion of Brief State Rumination Inventory (BSRI), Inventory, Visual Analogic Scale (VAS), Beck depression Inventory (BDI), IGroup presence questionnaire (IPQ)
-
Pulse and blood pressure measurements
Then again procedure for inducing ruminations .
At the end of ruminations induction :
-
Completion of Brief State Rumination Inventory (BSRI), State-Trait Anxiety (STAI), Inventory, Visual Analogic Scale (VAS), Beck depression Inventory (BDI), tolerance questionnaires
-
Debriefing
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: VR + active brain stimulation Exposure to a virtual reality world with active transcranial electric stimulation |
Device: VR + active brain stimulation
Active Brain stimulation (tDCS) is applied during exposition to virtual reality (20 minutes)
|
Sham Comparator: VR + sham brain stimulation Exposure to a virtual reality world with sham transcranial electric stimulation |
Device: VR +sham brain stimulation
Sham Brain stimulation (tDCS) is applied during exposition to virtual reality (20 minutes)
|
Outcome Measures
Primary Outcome Measures
- Change in anxious ruminations after anodal tDCS and virtual reality [within 1 week]
Change in anxious ruminations after anodal tDCS and virtual reality will be evaluated to compare the effects of tDCS associated with virtual reality versus virtual reality alone (+ tDCS placebo) to reduce ruminations. Evaluate with Brief State Ruminative Inventory (BSRI). It is a scale with 8 items. Each item is VAS with a score ranging between 0 and 100. The total score is sum of each item score (Total /800)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Without any particular ethnic and psychosocial criteria
-
Subject to ruminations (personality trait) documented by a RRS-SF score >30
-
Subjects with score to BDI scal <14 assessed during first visit
-
Subjects without psychiatric or addictive disorders.
-
Subjects who do not meet all the diagnostic criteria for an anxiety disorder or characterized depressive episode.
Exclusion Criteria:
-
contraindication to tDCS (neurosurgical history, intracranial device, skin problems)
-
current virtual reality intolerance
-
history of psychiatric or addictive disorders
-
Use of psychotropic drugs
-
Use of non psychotropic treatments significantly influencing mood or level of anxiety
-
pregnant or breast-feeding women
-
Neurological pathology, locomotor disability, or sensory (vestibular, visual, auditory ...)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University Hospital | Nantes | France |
Sponsors and Collaborators
- Nantes University Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- RC17_0390